The 26S Proteasome p54 is an essential component of the ubiquitin-proteasome system (UPS) in eukaryotic cells, playing a crucial role in protein degradation and cellular homeostasis. It functions as one of the catalytic subunits within the 20S core particle of the proteasome complex, responsible for cleaving peptide bonds in ubiquitinated proteins. Through this activity, the proteasome regulates the turnover of intracellular proteins, controlling various cellular processes such as cell cycle progression, DNA repair, and the removal of misfolded or damaged proteins.
Inhibition of 26S Proteasome p54 disrupts the normal protein degradation pathway, leading to the accumulation of ubiquitinated proteins within the cell. This accumulation can result from the direct binding of specific inhibitors to the active site of the proteasome, blocking its catalytic activity, or by interfering with the assembly and stability of the proteasome complex. The consequence of such inhibition is the perturbation of cellular homeostasis, as the clearance of regulatory proteins is impaired, leading to aberrant signaling and cellular dysfunction. Understanding the mechanisms of inhibition of 26S Proteasome p54 provides valuable insights into basic cellular biology and the consequences of disrupting protein degradation pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor that blocks the catalytic activity of the 26S proteasome by binding to its active site, thereby preventing the degradation of ubiquitinated proteins. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Inhibitor of the 26S proteasome that specifically targets the chymotrypsin-like activity of the proteasome, leading to the accumulation of ubiquitinated proteins and induction of apoptosis in cancer cells. | ||||||
Carfilzomib | 868540-17-4 | sc-396755 | 5 mg | $41.00 | ||
Selective proteasome inhibitor that irreversibly binds to the active site of the beta-5 subunit of the 20S proteasome, leading to the accumulation of misfolded proteins and induction of apoptosis. | ||||||
Ixazomib | 1072833-77-2 | sc-489103 sc-489103A | 10 mg 50 mg | $311.00 $719.00 | ||
Oral proteasome inhibitor that inhibits the beta-5 subunit of the 20S proteasome, leading to the accumulation of polyubiquitinated proteins and induction of apoptosis in cancer cells. | ||||||
Oprozomib | 935888-69-0 | sc-477447 | 2.5 mg | $280.00 | ||
Orally bioavailable proteasome inhibitor that irreversibly binds to the beta-5 subunit of the 20S proteasome, leading to the accumulation of misfolded proteins and apoptosis induction. | ||||||
Delanzomib, free base | 847499-27-8 | sc-396774 sc-396774A | 5 mg 10 mg | $160.00 $300.00 | ||
Proteasome inhibitor that blocks the chymotrypsin-like activity of the proteasome, resulting in the accumulation of ubiquitinated proteins and induction of apoptosis in cancer cells. | ||||||